BRCA2 Antikörper (AA 2308-2537)
Kurzübersicht für BRCA2 Antikörper (AA 2308-2537) (ABIN7568319)
Target
Alle BRCA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 2308-2537
-
Verwendungszweck
- Anti-Human BRCA2 Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human BRCA2 (Lys2308-His2537).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
-
Andere Bezeichnung
- BRCA2
-
Hintergrund
- BRCA2, FANCD1, FACD, Fanconi anemia group D1 protein, Breast cancer type 2 susceptibility protein
-
UniProt
- P51587
-
Pathways
- DNA Reparatur, M Phase, Maintenance of Protein Location
Target
-